FINWIRES · TerminalLIVE
FINWIRES

Neurocrine Posts Strong Q1 as Key Treatments Drive Growth, Morgan Stanley Says

By

Neurocrine Biosciences (NBIX) delivered a strong Q1, powered by rising demand for Ingrezza, its leading treatment for involuntary muscle movements, and an encouraging early launch of Crenessity, a new hormone-related therapy, Morgan Stanley said Wednesday in a report.

Ingrezza demand is tracking above the company's 2026 guidance, supported by record new patient starts, durable persistence and no inventory effects or other one-time items in the quarter, the report said.

Crenessity is a "definitive blockbuster in the making" with current sales reflecting only a fraction of its eventual potential as the launch remains early, Morgan Stanley said.

Neurocrine's acquisition of Soleno Therapeutics (SLNO) is expected to close around July 6, the report said.

Morgan Stanley raised its price target on Neurocrine stock to $191 from $185 and maintained its equal-weight rating.

Price: $145.19, Change: $+10.13, Percent Change: +7.50%

Related Articles

Wire

Workiva Q1 Adjusted Earnings, Revenue Rise; Shares Drop After Hours

Workiva (WK) reported Q1 adjusted earnings late Tuesday of $0.77 per diluted share, up from $0.14 a year earlier.Analysts polled by FactSet expected $0.65.Revenue for the three months ended March 31 rose to $247.3 million from $206.3 million a year earlier.Analysts surveyed by FactSet expected $245.2 million.Workiva expects Q2 adjusted EPS of $0.62 to $0.65 on revenue of $250 million to $252 million. Analysts expect EPS of $0.52 on revenue of $252.1 million.The company expects full-year adjusted EPS of $2.85 to $2.95 on revenue of $1.037 billion to $1.041 billion. Analysts expect EPS of $2.71 on revenue of $1.038 billion.Workiva shares fell 4.4% in after-hours trading.

$WK
Wire

SSR Mining Q1 Adjusted Earnings, Revenue Rise; Shares Gain After Hours

SSR Mining (SSRM) reported Q1 adjusted earnings late Tuesday of $1.15 per diluted share, up from $0.41 a year earlier.Analysts polled by FactSet expected $0.84.Revenue in the three months ended March 31 rose to $581.8 million from $316.6 million a year earlier.Four analysts surveyed by FactSet expected $536.4 million.SSR Mining shares rose 8% in after-hours trading.

$SSRM
Wire

Everus Construction Q1 Earnings, Revenue Rise; Shares Gain After Hours

Everus Construction Group (ECG) reported Q1 earnings late Tuesday of $1.14 per diluted share, up from $0.72 a year earlier.Analysts surveyed by FactSet expected $0.81.Revenue for the three months ended March 31 rose to $1.04 billion from $826.6 million a year earlier.Analysts polled by FactSet expected $933.8 million.The company raised full-year revenue guidance to $4.3 billion to $4.4 billion from the prior forecast of $4.1 billion to $4.2 billion.Analysts expect $4.23 billion.Everus shares rose 4.2% in after-hours trading.

$ECG